Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 09, 2024

BUY
$102.11 - $135.92 $3.87 Million - $5.15 Million
37,900 New
37,900 $4.87 Million
Q1 2022

May 11, 2022

BUY
$93.1 - $112.54 $21.1 Million - $25.5 Million
227,000 New
227,000 $25.2 Million
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $2.15 Million - $2.37 Million
-33,700 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$58.54 - $67.94 $398,072 - $461,992
-6,800 Reduced 16.79%
33,700 $2.21 Million
Q1 2020

May 13, 2020

SELL
$49.46 - $64.78 $108,812 - $142,516
-2,200 Reduced 5.15%
40,500 $2.44 Million
Q4 2018

Feb 13, 2019

BUY
$41.54 - $47.25 $49,848 - $56,700
1,200 Added 2.89%
42,700 $1.97 Million
Q4 2017

Feb 09, 2018

BUY
$47.53 - $53.73 $1.09 Million - $1.24 Million
23,000 Added 124.32%
41,500 $2.23 Million
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $761,275 - $910,570
18,500
18,500 $891,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $191B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.